Recent studies have demonstrated that upregulation and activation of TrkC have been observed in various types of cancer, such as medullary thyroid, breast, colon, lung, liver, and prostate cancer [15, 16]. This evidence concerns the gene NTRK3 and Familial prostate cancer.